Hostname: page-component-745bb68f8f-hvd4g Total loading time: 0 Render date: 2025-01-11T10:35:43.978Z Has data issue: false hasContentIssue false
  • English
  • Français

Improving Antimicrobial Stewardship The Evolution of Programmatic Strategies and Barriers

Part of: BARRY FARR AWARD RECIPIENTS

Published online by Cambridge University Press:  02 January 2015

Birgir Johannsson ,
Susan E. Beekmann ,
Arjun Srinivasan ,
Adam L. Hersh ,
Ramanan Laxminarayan ,
Philip M. Polgreen  and
on behalf of The Infectious Diseases Society of America Emerging Infections Network
Birgir Johannsson
Affiliation:
Carver College of Medicine, University of Iowa, Iowa City, Iowa
Susan E. Beekmann*
Affiliation:
Carver College of Medicine, University of Iowa, Iowa City, Iowa
Arjun Srinivasan
Affiliation:
Division of Healthcare Quality Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia
Adam L. Hersh
Affiliation:
Department of Pediatrics, University of Utah, Salt Lake City, Utah
Ramanan Laxminarayan
Affiliation:
Center for Disease Dynamics, Economics and Policy, Washington, DC, andPrinceton University, Princeton, New Jersey
Philip M. Polgreen
Affiliation:
Carver College of Medicine, University of Iowa, Iowa City, Iowa College of Public Health, University of Iowa, Iowa City, Iowa
*
Department of Internal Medicine, SW34J General Hospital, 200 Hawkins Drive, Iowa City, Iowa 52242 (susan-beekmann@uiowa.edu)
Get access Rights & Permissions [Opens in a new window]

Abstract

Objective.

To describe the prevalence and characteristics of antimicrobial stewardship programs (ASPs) in hospitals across the United States and to describe financial support provided for these programs.

Design.

Electronic and paper 14-question survey of infectious diseases physician members of the Infectious Diseases Society of America Emerging Infections Network (IDSA EIN).

Participants.

All 1,044 IDSA EIN members who care for adult patients were invited to participate.

Results.

Five hundred twenty-two (50%) members responded. Seventy-three percent of respondents reported that their institutions had or were planning an ASP, compared with 50% reporting the same thing in an EIN survey 10 years before. A shift was noted from formulary restriction alone to use of a set of tailored strategies designed to provide information and feedback to prescribers, particularly in community hospitals. Lack of funding and lack of personnel were reported as major barriers to implementing a program. Fifty-two percent of respondents with an ASP reported that infectious diseases physicians do not receive direct compensation for their participation in the ASP, compared with 18% 10 years ago.

Conclusions.

The percentage of institutions reporting ASPs has increased over the last decade, although small community hospitals were least likely to have these programs. In addition, ASP strategies have shifted dramatically. Lack of funding remains a key barrier for ASPs, and administrators need additional cost savings data in order to support ASPs. Interestingly, while guidelines and editorials regard compensated participation by an infectious diseases physician in these programs as critical, we found that more than half of the respondents reported no direct compensation for ASP activities.

Type
Original Article
Information
Infection Control & Hospital Epidemiology , Volume 32 , Issue 4 , April 2011 , pp. 367 - 374
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2011

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

a

5th Decennial International Conference on Healthcare-Associated Infection; Atlanta, Georgia; March 2010.

References

1. Maragakis, LL, Perencevich, EN, Cosgrove, SE. Clinical and economic burden of antimicrobial resistance. Expert Rev Anti Infect Ther 2008;6:751–763.Google Scholar
2. Roberts, RR, Hota, B, Ahmad, I, et al. Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship. Clin Infect Dis 2009;49:1175–1184.Google Scholar
3. Lipsitch, M, Samore, MH. Antimicrobial use and antimicrobial resistance: a population perspective. Emerg Infect Dis 2002;8:347–354.Google Scholar
4. McGowan, JE Jr. Finland, M. Usage of antibiotics in a general hospital: effect of requiring justification. J Infect Dis 1974;130:165–168.Google Scholar
5. Scheckler, WE, Bennett, JV. Antibiotic usage in seven community hospitals. JAMA 1970;213:264–267.Google Scholar
6. Dellit, TH, Owens, RC, McGowan, JE Jr., et al. Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis 2007;44:159–177.Google Scholar
7. The Research Committee of SHEA. Enhancing patient safety by reducing healthcare-associated infections: the role of discovery and dissemination. Infect Control Hosp Epidemiol 2010;31:118–123.Google Scholar
8. Sunenshine, RH, Liedtke, LA, Jernigan, DB, Strausbaugh, LJ. Role of infectious diseases consultants in management of antimicrobial use in hospitals. Clin Infect Dis 2004;38:934–938.Google Scholar
9. Executive Committee of the Infectious Diseases Society of America Emerging Infections Network. The emerging infections network: a new venture for the Infectious Diseases Society of America. Clin Infect Dis 1997;25:34–36.Google Scholar
10. Lawton, RM, Fridkin, SK, Gaynes, RP, McGowan, JE Jr. Practices to improve antimicrobial use at 47 US hospitals: the status of the 1997 SHEA/IDSA position paper recommendations. Society for Healthcare Epidemiology of America/Infectious Diseases Society of America. Infect Control Hosp Epidemiol 2000;21:256–259.Google Scholar
11. Weinstein, RA. Controlling antimicrobial resistance in hospitals: infection control and use of antibiotics. Emerg Infect Dis 2001;7:188–192.Google Scholar
12. Zaoutis, TE. Antibiotic resistance: who will pay the bills? Clin Infect Dis 2009;49:1185–1186.Google Scholar
13. McGowan, JE Jr. Minimizing antimicrobial resistance: the key role of the infectious diseases physician. Clin Infect Dis 2004;38:939–942.Google Scholar
14. McQuillen, DP, Petrak, RM, Wasserman, RB, Nahass, RG, Scull, JA, Martinelli, LP. The value of infectious diseases specialists: non-patient care activities. Clin Infect Dis 2008;47:1051–1063.Google Scholar
15. Zillich, AJ, Sutherland, JM, Wilson, SJ, et al. Antimicrobial use control measures to prevent and control antimicrobial resistance in US hospitals. Infect Control Hosp Epidemiol 2006;27:1088–1095.Google Scholar
16. Nault, V, Beaudoin, M, Thirion, DJ, Gosselin, M, Cossette, B, Va-liquette, L. Antimicrobial stewardship in acute care centres: a survey of 68 hospitals in Quebec. Can J Infect Dis Med Microbiol 2008;19:237–242.Google Scholar
17. Pope, SD, Dellit, TH, Owens, RC, Hooton, TM. Results of survey on implementation of Infectious Diseases Society of America and Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Infect Control Hosp Epidemiol 2009;30:97–98.Google Scholar
18. Hersh, AL, Beekmann, SE, Polgreen, PM, Zaoutis, TE, Newland, JG. Antimicrobial stewardship programs in pediatrics. Infect Control Hosp Epidemiol 2009;30:1211–1217.Google Scholar
19. Drew, RH, White, R, MacDougall, C, Hermsen, ED, Owens, RC Jr. Insights from the Society of Infectious Diseases Pharmacists on antimicrobial stewardship guidelines from the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America. Pharmacotherapy 2009;29:593–607.Google Scholar
20. Owens, RC Jr. Antimicrobial stewardship: concepts and strategies in the 21st century. Diagn Microbiol Infect Dis 2008;61:110–128.Google Scholar
21. Arnold, FW, McDonald, LC, Smith, RS, Newman, D, Ramirez, JA. Improving antimicrobial use in the hospital setting by providing usage feedback to prescribing physicians. Infect Control Hosp Epidemiol 2006;27:378–382.Google Scholar
22. Cosgrove, SE, Patel, A, Song, X, et al. Impact of different methods of feedback to clinicians after postprescription antimicrobial review based on the Centers for Disease Control and Prevention's 12 steps to prevent antimicrobial resistance among hospitalized adults. Infect Control Hosp Epidemiol 2007;28:641–646.Google Scholar
23. Di Pentima, MC, Chan, S. Impact of antimicrobial stewardship program on vancomycin use in a pediatric teaching hospital. Pediatr Infect Dis J 2010;29:707–711.Google Scholar
24. Agwu, AL, Lee, CK, Jain, SK, et al. A World Wide Web-based antimicrobial stewardship program improves efficiency, communication, and user satisfaction and reduces cost in a tertiary care pediatric medical center. Clin Infect Dis 2008;47:747–753.Google Scholar
25. John, JF Jr., Fishman, NO. Programmatic role of the infectious diseases physician in controlling antimicrobial costs in the hospital. Clin Infect Dis 1997;24:471–485.Google Scholar
26. Bannan, A, Buono, E, McLaws, ML, Gottlieb, T. A survey of medical staff attitudes to an antibiotic approval and stewardship programme. Intern Med J 2009;39:662–668.Google Scholar
27. Wright, SB, Ostrowsky, B, Fishman, N, Deloney, VM, Mermel, L, Perl, TM. Expanding roles of healthcare epidemiology and infection control in spite of limited resources and compensation. Infect Control Hosp Epidemiol 2010;31:127–132.Google Scholar
28. Frank, MO, Batteiger, BE, Sorensen, SJ, et al. Decrease in expenditures and selected nosocomial infections following implementation of an antimicrobial-prescribing improvement program. Clin Perform Qual Health Care 1997;5:180–188.Google Scholar
29. Fraser, GL, Stogsdill, P, Dickens, JD Jr, Wennberg, DE, Smith, RP Jr, Prato, BS. Antibiotic optimization: an evaluation of patient safety and economic outcomes. Arch Intern Med 1997;157:1689–1694.Google Scholar
30. Gross, R, Morgan, AS, Kinky, DE, Weiner, M, Gibson, GA, Fishman, NO. Impact of a hospital-based antimicrobial management program on clinical and economic outcomes. Clin Infect Dis 2001;33:289–295.Google Scholar
31. Ng, CK, Wu, TC, Chan, WM, et al. Clinical and economic impact of an antibiotics stewardship programme in a regional hospital in Hong Kong. Qual Saf Health Care 2008;17:387–392.Google Scholar
32. Kuntz, JL, Cavanaugh, JE, Becker, LK, et al. Clostridium difficile-associated disease in patients in a small rural hospital. Infect Control Hosp Epidemiol 2007;28:1236–1239.Google Scholar
33. Sintchenko, V, Coiera, E, Gilbert, GL. Decision support systems for antibiotic prescribing. Curr Opin Infect Dis 2008;21:573–579.Google Scholar